Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer
A Schneeweiss, M Hensel, R Goerner, T Khbeis… - Stem …, 2001 - academic.oup.com
In patients with metastatic breast cancer (MBC), early dose intensification with multiple
cycles of peripheral blood stem cell-supported high-dose chemotherapy (HDCT) seems …
cycles of peripheral blood stem cell-supported high-dose chemotherapy (HDCT) seems …
Randomized trial of single compared with tandem high-dose chemotherapy followed by autologous stem-cell transplantation in patients with chemotherapy-sensitive …
Purpose To compare progression-free survival between single and tandem high-dose
chemotherapy (HDT) followed by autologous stem-cell transplantation in chemotherapy …
chemotherapy (HDT) followed by autologous stem-cell transplantation in chemotherapy …
A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a …
A Bashey, S Corringham, J Garrett, TA Lane… - Bone Marrow …, 2000 - nature.com
Multi-cycle high-dose chemotherapy with autologous stem cell support (HDC-ASCS) may
improve the results obtained with single-cycle HDC-ASCS in metastatic breast cancer …
improve the results obtained with single-cycle HDC-ASCS in metastatic breast cancer …
Effect of induction chemotherapy and tandem cycles of high-dose chemotherapy on outcomes in autologous stem cell transplant for metastatic breast cancer
AL Pecora, HM Lazarus, EA Stadtmauer… - Bone marrow …, 2001 - nature.com
We assessed the effect standard-dose induction chemotherapy and tandem cycles of high-
dose chemotherapy (HDC) have on outcomes in metastatic breast cancer. One hundred and …
dose chemotherapy (HDC) have on outcomes in metastatic breast cancer. One hundred and …
High-dose chemotherapy with autologous stem-cell support versus standard-dose chemotherapy: meta-analysis of individual patient data from 6 randomized …
Abstract Abstract# 6113 Background: The role of high-dose chemotherapy (HDC) with
autologous hematopoietic stem-cell transplantation for metastatic breast cancer has not …
autologous hematopoietic stem-cell transplantation for metastatic breast cancer has not …
High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and …
PURPOSE: To assess survival of patients with metastatic breast cancer treated with high-
dose chemotherapy (HDC) versus standard-dose chemotherapy (SDC). PATIENTS AND …
dose chemotherapy (HDC) versus standard-dose chemotherapy (SDC). PATIENTS AND …
Status of high-dose chemotherapy for breast cancer: a review
Y Nieto, RE Champlin, JR Wingard… - Biology of Blood and …, 2000 - Elsevier
The purpose of this review is to analyze the current status of high-dose chemotherapy
(HDCT) with autologous stem cell transplantation for patients with breast cancer. Current …
(HDCT) with autologous stem cell transplantation for patients with breast cancer. Current …
High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials
Purpose High doses of effective chemotherapy are compelling if they can be delivered
safely. Substantial interest in supporting high-dose chemotherapy with bone marrow or …
safely. Substantial interest in supporting high-dose chemotherapy with bone marrow or …
Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer
EA Stadtmauer, A O'Neill, LJ Goldstein… - … England Journal of …, 2000 - Mass Medical Soc
Background We conducted a randomized trial in which we compared high-dose
chemotherapy plus hematopoietic stem-cell rescue with a prolonged course of monthly …
chemotherapy plus hematopoietic stem-cell rescue with a prolonged course of monthly …
High-dose chemotherapy and autologous stem cell transplant in women with de novo chemosensitive metastatic breast cancer
SM Stemmer, I Hardan, HJ Brenner… - American journal of …, 2004 - journals.lww.com
The prognosis of patients with de novo stage IV breast cancer seems to be similar to that of
patients with metastatic disease. Because these patients have not been exposed to prior …
patients with metastatic disease. Because these patients have not been exposed to prior …